VistaGen Therapeutics Inc. Share Price Today, Forecast Target, Chat & Where To Buy [VTGN]

Home > Share Prices > VistaGen Therapeutics Inc. share price (VTGN)

Today's VistaGen Therapeutics Inc. share price is 3.53 (as of 16:00 26-Sep-2025) which is a change of 0.16 or 4.75% from the last closing price of 3.53 with 287,812 shares traded giving VistaGen Therapeutics Inc. a market capitalisation of 105,405,693. The most recent daily high has been 3.58 and daily low 3.31. The VistaGen Therapeutics Inc. share price 52 week high has been 3.88 and the 52 week low 1.9. Based on the most recent VistaGen Therapeutics Inc. share price opening of 3.53, the current VistaGen Therapeutics Inc. EPS (earnings per share) are -1.79 and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying VistaGen Therapeutics Inc. Shares

It currently costs 3.53 to buy one share in VistaGen Therapeutics Inc. (as of 16:00 26-Sep-2025) which is a change of 0.16 or 4.75% from the last closing price of 3.37. To buy shares in VistaGen Therapeutics Inc. you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is VistaGen Therapeutics Inc. A Good Investment?

The below VistaGen Therapeutics Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top